The induction of iNOS and increased lipid peroxidation in liver have repeatedly been shown to be associated with the development of NAFLD, both in humans with NAFLD [36] and animal models of the disease [26]. The gene discussed is NOS2; the disease is metabolic dysfunction-associated steatotic liver disease.